COVID-19 risks in rheumatic disease remain unclearNovember 7, 2020Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisLupus & Connective Tissue DiseasesCOVID-19 UpdatesAnkylosing spondylitis
Data on potential risks of COVID-19 in psoriasis patients limited, but reassuringOctober 23, 2020COVID-19 UpdatesPsoriatic Arthritis
Non-Whites remain sorely underrepresented in phase 3 psoriasis trialsOctober 20, 2020Psoriatic Arthritis
FDA issues new NSAIDs warning for second half of pregnancyOctober 16, 2020SpondyloarthropathiesAnkylosing spondylitisRheumatoid ArthritisPsoriatic ArthritisOsteoarthritisPain
Guselkumab improvements for psoriatic arthritis persist through 1 yearOctober 15, 2020Psoriatic Arthritis
Study highlights differences between White and Latino patients with psoriasisOctober 6, 2020Psoriatic Arthritis
Experts assess infection risks for patients on biologicsOctober 6, 2020Rheumatoid ArthritisPsoriatic Arthritis
Shingrix effective in older adults with preexisting immune-mediated disordersOctober 5, 2020Psoriatic ArthritisRheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitis
Golimumab approval extended to polyarticular-course JIA and juvenile PsAOctober 2, 2020Psoriatic ArthritisPediatrics
Strategic approach mitigates impact of antidrug antibodies in patients with rheumatic diseasesSeptember 23, 2020Rheumatoid ArthritisPsoriatic ArthritisAnkylosing spondylitisSpondyloarthropathies
Dr. Len Calabrese gives advice on vaccinating adult patients with rheumatic diseaseSeptember 23, 2020Rheumatoid ArthritisPsoriatic ArthritisLupus & Connective Tissue DiseasesGoutAnkylosing spondylitisSpondyloarthropathies
Study results suggest ustekinumab may trigger acute CV events early in treatmentSeptember 18, 2020Psoriatic Arthritis
